Epigenetic regulation of nociceptin/orphanin FQ and corticotropin-releasing factor system genes in frustration stress-induced binge-like palatable food consumption
Abstract:Evidence suggests that binge eating may be caused by a unique interaction between dieting and stress. We developed a binge-eating model in which female rats with a history of intermittent food restriction show binge-like palatable food consumption after a 15-minute exposure to the sight of the palatable food (frustration stress). The aim of the present study was to investigate the regulation of the stress neurohormone corticotropin-releasing factor (CRF) system and of the nociceptin/orphanin FQ (N/OFQ) system … Show more
“…3.1 | Binge-eating behavior in rats exposed to food restriction and binge-eating test As reported in previous studies Micioni Di Bonaventura et al, 2014;Pucci et al, 2016), we found that rats lose weight during the food restriction period but they regain it during the subsequent free-food period. On the last day of the BE FIGURE 2 Schematic representation of the rat faah gene and the 5 0 upstream region.…”
Section: Resultssupporting
confidence: 78%
“…In this work, the combination of stress and repeated food restriction induced binge-eating behavior for highly palatable food in female rats as shown previously (Cifani et al, 2009;Piccoli et al, 2012), where regulation of nociceptin/orphanin FQ and corticotropin-releasing factor genes was reported as a potential contributor Pucci et al, 2016). Here, we extended our previous investigations to the role of ECS gene regulation in the same animal model.…”
Section: Discussionsupporting
confidence: 71%
“…Stress and food restriction-induced changes in the expression of ECS genes in several brain regions were assessed by qRT-PCR as described previously (D'Addario et al, 2017;Pucci et al, 2016). Specifically, expression of cnr1, cnr2, the gene coding for CB receptors, CB 3 (GPR55) receptors and TRPV1 was analyzed as well as the expression of the enzymes involved on biosynthesis (DAGL and NAPE-PLD) and degradation (MAGL and FAAH) of eCBs.…”
Section: Analysis Of Gene Expression By Quantitative Real-time Revementioning
Objective: Binge-eating episodes are recurrent and are defining features of several eating disorders. Thus binge-eating episodes might influence eating disorder development of which exact underlying mechanisms are still largely unknown.Methods: Here we focused on the transcriptional regulation of the endocannabinoid system, a potent regulator of feeding behavior, in relevant rat brain regions, using a rat model in which a history of intermittent food restriction and a frustration stress induce binge-like palatable food consumption.
Results: We observed a selective down-regulation of fatty acid amide hydrolase (faah) gene expression in the hypothalamus of rats showing the binge-eating behavior with a consistent reduction in histone 3 acetylation at lysine 4 of the gene promoter. No relevant changes were detected for any other endocannabinoid system components in any brain regions under study, as well as for the other epigenetic mechanisms investigated (DNA methylation and histone 3 lysine 27 methylation) at the faah gene promoter.Discussion: Our findings suggest that faah transcriptional regulation is a potential biomarker of binge-eating episodes, with a relevant role in the homeostatic regulation of food intake.
“…3.1 | Binge-eating behavior in rats exposed to food restriction and binge-eating test As reported in previous studies Micioni Di Bonaventura et al, 2014;Pucci et al, 2016), we found that rats lose weight during the food restriction period but they regain it during the subsequent free-food period. On the last day of the BE FIGURE 2 Schematic representation of the rat faah gene and the 5 0 upstream region.…”
Section: Resultssupporting
confidence: 78%
“…In this work, the combination of stress and repeated food restriction induced binge-eating behavior for highly palatable food in female rats as shown previously (Cifani et al, 2009;Piccoli et al, 2012), where regulation of nociceptin/orphanin FQ and corticotropin-releasing factor genes was reported as a potential contributor Pucci et al, 2016). Here, we extended our previous investigations to the role of ECS gene regulation in the same animal model.…”
Section: Discussionsupporting
confidence: 71%
“…Stress and food restriction-induced changes in the expression of ECS genes in several brain regions were assessed by qRT-PCR as described previously (D'Addario et al, 2017;Pucci et al, 2016). Specifically, expression of cnr1, cnr2, the gene coding for CB receptors, CB 3 (GPR55) receptors and TRPV1 was analyzed as well as the expression of the enzymes involved on biosynthesis (DAGL and NAPE-PLD) and degradation (MAGL and FAAH) of eCBs.…”
Section: Analysis Of Gene Expression By Quantitative Real-time Revementioning
Objective: Binge-eating episodes are recurrent and are defining features of several eating disorders. Thus binge-eating episodes might influence eating disorder development of which exact underlying mechanisms are still largely unknown.Methods: Here we focused on the transcriptional regulation of the endocannabinoid system, a potent regulator of feeding behavior, in relevant rat brain regions, using a rat model in which a history of intermittent food restriction and a frustration stress induce binge-like palatable food consumption.
Results: We observed a selective down-regulation of fatty acid amide hydrolase (faah) gene expression in the hypothalamus of rats showing the binge-eating behavior with a consistent reduction in histone 3 acetylation at lysine 4 of the gene promoter. No relevant changes were detected for any other endocannabinoid system components in any brain regions under study, as well as for the other epigenetic mechanisms investigated (DNA methylation and histone 3 lysine 27 methylation) at the faah gene promoter.Discussion: Our findings suggest that faah transcriptional regulation is a potential biomarker of binge-eating episodes, with a relevant role in the homeostatic regulation of food intake.
“…Cifani et al, 2010; C. Cifani et al, 2009; Micioni Di Bonaventura, Cifani, et al, 2012; Micioni Di Bonaventura, Vitale, et al, 2012; Pucci et al, 2015), body weight of rats was reduced during the 4 days of food restriction, but immediately afterwards the animals increased their food intake and rapidly recovered their body weight to levels of controls by the end of each cycle. On the test day body weight of animals, as well as their food intake in the previous 24 h, were not significantly different among the groups (data not shown).…”
Rationale
The interaction between dieting and stress is a key factor for triggering binge episodes on palatable food in human binge eaters. Corticotropin releasing factor (CRF) mechanisms are known to play a pivotal role in the regulation of this maladaptive behavior.
Objective
The present study evaluated the effect of systemic injection of the CRF1 receptor antagonist R121919, the corticosterone synthesis inhibitor metyrapone and central amygdala (CeA) injections of the nonselective CRF antagonist D-Phe-CRF(12â 41) in rats in which binge eating was evoked by stress and cycles of food restriction.
Method
Female rats were subjected or not to repeated cycles of regular chow food restriction/refeeding during which they were also given limited access (2 h) to palatable food. On the test day, rats were either exposed or not to the sight of the palatable food for 15 min without allowing access, before assessing food consumption.
Results
Systemic injections of R121919, but not of the metyrapone, blocked binge-like eating behavior. Restricted and stressed rats showed up-regulation of crh1 receptor mRNA signal in the bed nucleus of the stria terminalis and CeA but not in basolateral amygdala (BLA) or in the paraventricular nucleus. Injection D-Phe-CRF(12â 41) in CeA but not in the BLA blocked binge-like eating behavior.
Discussion
These findings demonstrate that extra-hypothalamic CRF1 receptors, rather than those involved in endocrine functions, are involved in binge eating and the crucial role of CRF receptors in CeA. CRF1 receptor antagonism may represent a novel pharmacological treatment for binge-related eating disorders.
“…A recent systematic review (Torensma et al, 2016) included two studies suggesting that obese subjects have a lower pain threshold than nonobese subjects (Pradalier et al, 1981;McKendall and Haier, 1983), but four studies indicating that obese subjects have a higher one (Zahorska-Markiewicz et al, 1988;Miscio et al, 2005;Maffiuletti et al, 2011;Dodet et al, 2013). Other findings concluded that body mass index and body fat may influence the pain threshold (Bohnert et al, 2013;Price et al, 2013;Tashani et al, 2017;Torensma et al, 2017), and the intensity of the perception of stimuli changes proportionally with the levels of subcutaneous fat in the affected body area. Price et al (2013) reported that obese people have a higher pain threshold in the abdominal area compared to the hands and forearms.…”
There is a strong relationship between palatable diet and pain sensitivity, and the cannabinoid and opioid systems might play an important role in this correlation. The palatable diet used in many animal models of obesity is the cafeteria (CAF) diet, based on human food with high sugar, salt, and fat content. In this study, we investigated whether long-term exposure to a CAF diet could modify pain sensitivity and explored the role of the cannabinergic system in this modification. Male Sprague-Dawley rats were divided into two groups: one fed with standard chow only (CO) and the other with extended access (EA) to a CAF diet. Hot plate and tail flick tests were used to evaluate pain sensitivity. At the end of a 40-day CAF exposure, EA rats showed a significant increase in the pain threshold compared to CO rats, finding probably due to up-regulation of CB1 and mu-opioid receptors. Instead, during abstinence from palatable foods, EA animals showed a significant increase in pain sensibility, which was ameliorated by repeated treatment with a fatty acid amide hydrolase inhibitor, PF-3845 (10 mg/kg, intraperitoneally), every other day for 28 days. Ex vivo analysis of the brains of these rats clearly showed that this effect was mediated by mu-opioid receptors, which were up-regulated following repeated treatment of PF-3845. Our data add to the knowledge about changes in pain perception in obese subjects, revealing a key role of CB1 and mu-opioid receptors and their possible pharmacological crosstalk and reinforcing the need to consider this modulation in planning effective pain management for obese patients.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citationsâcitations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.